Meropenem tolerance in a patient with probable fulminant piperacillin-induced immune hemolytic anemia

J Allergy Clin Immunol Pract. 2015 May-Jun;3(3):452-3. doi: 10.1016/j.jaip.2014.12.015. Epub 2015 Feb 11.

Authors

Benjamin T Prince¹, Brandon J McMahon², Manu Jain³, Anju T Peters⁴

Affiliations

¹ Division of Allergy-Immunology, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Ill.
² Division of Hematology-Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill.
³ Division of Pulmonology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill.
⁴ Division of Allergy-Immunology, Department of Medicine, Northwestern Feinberg School of Medicine, Chicago, Ill. Electronic address: anjupeters@northwestern.edu.

PMID: 25680924
DOI: 10.1016/j.jaip.2014.12.015

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Anemia, Hemolytic / blood
Anemia, Hemolytic / chemically induced*
Anemia, Hemolytic / diagnosis
Anemia, Hemolytic / immunology
Anti-Bacterial Agents / adverse effects*
Cystic Fibrosis / diagnosis
Cystic Fibrosis / drug therapy*
Cystic Fibrosis / microbiology
Disease Progression
Drug Hypersensitivity / blood
Drug Hypersensitivity / diagnosis
Drug Hypersensitivity / etiology*
Drug Hypersensitivity / immunology
Female
Humans
Immunologic Tests
Meropenem
Microbial Sensitivity Tests
Piperacillin / adverse effects*
Predictive Value of Tests
Pseudomonas Infections / diagnosis
Pseudomonas Infections / drug therapy*
Pseudomonas Infections / microbiology
Respiratory Tract Infections / diagnosis
Respiratory Tract Infections / drug therapy*
Respiratory Tract Infections / microbiology
Thienamycins / therapeutic use*
Treatment Outcome

Substances

Anti-Bacterial Agents
Thienamycins
Meropenem
Piperacillin